Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Wei Chiu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Trials (London, England)|December 1, 2020
Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verificationOsamu Yamada, Shih-Wei Chiu, Munenori Takata, et al.
Plos One|October 23, 2024
Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRSTMasahiro Nomoto, Yoshio Tsuboi, Kenichi Kashihara, et al.
Parkinsonism & Related Disorders|March 11, 2017
Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centersTetsuya Maeda, Yasushi Shimo, Shih-Wei Chiu, et al.
Journal of the Neurological Sciences|April 6, 2023
Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRSTTakayasu Mishima, Shih-Wei Chiu, Hidemoto Saiki, et al.
ACS Applied Materials & Interfaces|June 13, 2023
Achieving Bright Organic Light-Emitting Field-Effect Transistors with Sustained Efficiency through Hybrid Contact DesignShih-Wei Chiu, An Hsu, Lei Ying, et al.
Trials|June 14, 2024
Effectiveness of remote risk-based monitoring and potential benefits for combination with direct data captureOsamu Yamada, Shih-Wei Chiu, Toru Nakazawa, et al.
Modern Rheumatology|January 25, 2018
Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosusTomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, et al.
Journal of Palliative Medicine|February 10, 2025
Prediction of Next-Day Survival in Imminently Dying Cancer Patients: A Multicenter Cohort StudyMasanori Mori, Takuhiro Yamaguchi, Isseki Maeda, et al.
International Journal of Clinical Oncology|February 28, 2025
Impact of genetic mutations on prognosis and chemotherapy efficacy in advanced appendiceal carcinoma: insights from the nationwide Japanese comprehensive genomic profiling test databaseSakura Hiraide Taniguchi, Masanobu Takahashi, Shih-Wei Chiu, et al.
Therapeutic Innovation & Regulatory Science|July 2, 2024
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in OncologyHiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Trials (London, England)|December 1, 2020
Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verificationOsamu Yamada, Shih-Wei Chiu, Munenori Takata, et al.
Plos One|October 23, 2024
Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRSTMasahiro Nomoto, Yoshio Tsuboi, Kenichi Kashihara, et al.
Parkinsonism & Related Disorders|March 11, 2017
Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centersTetsuya Maeda, Yasushi Shimo, Shih-Wei Chiu, et al.
Journal of the Neurological Sciences|April 6, 2023
Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRSTTakayasu Mishima, Shih-Wei Chiu, Hidemoto Saiki, et al.
ACS Applied Materials & Interfaces|June 13, 2023
Achieving Bright Organic Light-Emitting Field-Effect Transistors with Sustained Efficiency through Hybrid Contact DesignShih-Wei Chiu, An Hsu, Lei Ying, et al.
Trials|June 14, 2024
Effectiveness of remote risk-based monitoring and potential benefits for combination with direct data captureOsamu Yamada, Shih-Wei Chiu, Toru Nakazawa, et al.
Modern Rheumatology|January 25, 2018
Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosusTomonori Ishii, Yoshiya Tanaka, Atsushi Kawakami, et al.
Journal of Palliative Medicine|February 10, 2025
Prediction of Next-Day Survival in Imminently Dying Cancer Patients: A Multicenter Cohort StudyMasanori Mori, Takuhiro Yamaguchi, Isseki Maeda, et al.
International Journal of Clinical Oncology|February 28, 2025
Impact of genetic mutations on prognosis and chemotherapy efficacy in advanced appendiceal carcinoma: insights from the nationwide Japanese comprehensive genomic profiling test databaseSakura Hiraide Taniguchi, Masanobu Takahashi, Shih-Wei Chiu, et al.
Therapeutic Innovation & Regulatory Science|July 2, 2024
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in OncologyHiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, et al.
Pageof 3